Story perspectives

FDA Recalls 11,100 Ziac Bottles Over Contamination Risk

12/9/2025

Summary

Story summary

The U.S. Food and Drug Administration recalled 11,100 Ziac bottles due to cross-contamination with ezetimibe.
Recall was issued December 1 and targets Glenmark Pharmaceuticals 2.5 mg and 6.25 mg tablets manufactured in New Jersey.
Recall is Class III, indicating low risk, and neither Glenmark Pharmaceuticals nor the U.S. FDA has provided guidance.
Affected bottles include 30-count, 100-count, 500-count sizes, with expiration dates from November 2025 to May 2026.

1 of 1

Story summary

The U.S. Food and Drug Administration recalled 11,100 Ziac bottles due to cross-contamination with ezetimibe.
Recall was issued December 1 and targets Glenmark Pharmaceuticals 2.5 mg and 6.25 mg tablets manufactured in New Jersey.
Recall is Class III, indicating low risk, and neither Glenmark Pharmaceuticals nor the U.S. FDA has provided guidance.
Affected bottles include 30-count, 100-count, 500-count sizes, with expiration dates from November 2025 to May 2026.